Experiment: 2MYX

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	50 mM sodium phosphate, 100 mM sodium chloride, 5 % D2O, 0.01 % sodium azide, 4.6 mM protease inhibitor cocktail, 1.2 mM [U-98% 13C; U-98% 15N] CUE domain of Cue1, 100 uM DSS	95% H2O/5% D2O	100	7.0	ambient	298
2	3D HNCACB	50 mM sodium phosphate, 100 mM sodium chloride, 5 % D2O, 0.01 % sodium azide, 4.6 mM protease inhibitor cocktail, 1.2 mM [U-98% 13C; U-98% 15N] CUE domain of Cue1, 100 uM DSS	95% H2O/5% D2O	100	7.0	ambient	298
3	3D HNCO	50 mM sodium phosphate, 100 mM sodium chloride, 5 % D2O, 0.01 % sodium azide, 4.6 mM protease inhibitor cocktail, 1.2 mM [U-98% 13C; U-98% 15N] CUE domain of Cue1, 100 uM DSS	95% H2O/5% D2O	100	7.0	ambient	298
4	3D 1H-15N NOESY	50 mM sodium phosphate, 100 mM sodium chloride, 5 % D2O, 0.01 % sodium azide, 4.6 mM protease inhibitor cocktail, 1.2 mM [U-98% 13C; U-98% 15N] CUE domain of Cue1, 100 uM DSS	95% H2O/5% D2O	100	7.0	ambient	298
5	3D 1H-13C NOESY aliphatic	50 mM sodium phosphate, 100 mM sodium chloride, 5 % D2O, 0.01 % sodium azide, 4.6 mM protease inhibitor cocktail, 1.2 mM [U-98% 13C; U-98% 15N] CUE domain of Cue1, 100 uM DSS	95% H2O/5% D2O	100	7.0	ambient	298
6	3D 1H-13C NOESY aromatic	50 mM sodium phosphate, 100 mM sodium chloride, 5 % D2O, 0.01 % sodium azide, 4.6 mM protease inhibitor cocktail, 1.2 mM [U-98% 13C; U-98% 15N] CUE domain of Cue1, 100 uM DSS	95% H2O/5% D2O	100	7.0	ambient	298
7	3D long range 1H-15N TROSY HNCO	50 mM sodium phosphate, 100 mM sodium chloride, 5 % D2O, 0.01 % sodium azide, 4.6 mM protease inhibitor cocktail, 1.2 mM [U-98% 13C; U-98% 15N] CUE domain of Cue1, 100 uM DSS	95% H2O/5% D2O	100	7.0	ambient	298
8	3D HN(CA)CO	50 mM sodium phosphate, 100 mM sodium chloride, 5 % D2O, 0.01 % sodium azide, 4.6 mM protease inhibitor cocktail, 1.2 mM [U-98% 13C; U-98% 15N] CUE domain of Cue1, 100 uM DSS	95% H2O/5% D2O	100	7.0	ambient	298
9	2D 1H-13C HSQC	50 mM sodium phosphate, 100 mM sodium chloride, 5 % D2O, 0.01 % sodium azide, 4.6 mM protease inhibitor cocktail, 1.2 mM [U-98% 13C; U-98% 15N] CUE domain of Cue1, 100 uM DSS	95% H2O/5% D2O	100	7.0	ambient	298
10	2D 1H-13C ct TROSY H(C)N	50 mM sodium phosphate, 100 mM sodium chloride, 5 % D2O, 0.01 % sodium azide, 4.6 mM protease inhibitor cocktail, 1.2 mM [U-98% 13C; U-98% 15N] CUE domain of Cue1, 100 uM DSS	95% H2O/5% D2O	100	7.0	ambient	298
11	2D (H)CB(CG)CCH-TOCSY	50 mM sodium phosphate, 100 mM sodium chloride, 5 % D2O, 0.01 % sodium azide, 4.6 mM protease inhibitor cocktail, 1.2 mM [U-98% 13C; U-98% 15N] CUE domain of Cue1, 100 uM DSS	95% H2O/5% D2O	100	7.0	ambient	298
12	2D (HB)CB(CGCD)HD	50 mM sodium phosphate, 100 mM sodium chloride, 5 % D2O, 0.01 % sodium azide, 4.6 mM protease inhibitor cocktail, 1.2 mM [U-98% 13C; U-98% 15N] CUE domain of Cue1, 100 uM DSS	95% H2O/5% D2O	100	7.0	ambient	298
13	3D H(CC)(CO)NH TOCSY	50 mM sodium phosphate, 100 mM sodium chloride, 5 % D2O, 0.01 % sodium azide, 4.6 mM protease inhibitor cocktail, 1.2 mM [U-98% 13C; U-98% 15N] CUE domain of Cue1, 100 uM DSS	95% H2O/5% D2O	100	7.0	ambient	298
14	3D (H)C(C)(CO)NH TOCSY	50 mM sodium phosphate, 100 mM sodium chloride, 5 % D2O, 0.01 % sodium azide, 4.6 mM protease inhibitor cocktail, 1.2 mM [U-98% 13C; U-98% 15N] CUE domain of Cue1, 100 uM DSS	95% H2O/5% D2O	100	7.0	ambient	298
15	2D 1H-15N BEST TROSY H(N)N	50 mM sodium phosphate, 100 mM sodium chloride, 5 % D2O, 0.01 % sodium azide, 4.6 mM protease inhibitor cocktail, 1.2 mM [U-98% 13C; U-98% 15N] CUE domain of Cue1, 100 uM DSS	95% H2O/5% D2O	100	7.0	ambient	298

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	800
2	Bruker	AVANCE	700
3	Bruker	AVANCE	600
4	Bruker	AVANCE	500

NMR Refinement
Method	Details	Software
molecular dynamics		CYANA

NMR Ensemble Information
Conformer Selection Criteria	target function
Conformers Calculated Total Number	100
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	structure solution	CYANA	3.96	Guntert, Mumenthaler and Wuthrich
2	processing	TopSpin	3.1	Bruker Biospin
3	chemical shift assignment	Sparky	3.115	Goddard
4	refinement	OPALp		Luginbuhl, Guntert, Billeter and Wuthrich
5	dihedral angle constraints	TALOS		Cornilescu, Delaglio and Bax

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.